Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4820 (99th)

Prescription Drug Marketing Act of 1986

reportedUnited States· United States Congress· EN

Introduced

14 May 1986

Last action

7 October 1986 · Committee

Status

Ordered to be Reported (Amended).

Sponsors

Rep. Dingell, John D. [D-MI-12], Rep. Broyhill, James T. [R-NC-10], Sen. Wyden, Ron [D-OR], Rep. Eckart, Dennis E. [D-OH-11], Rep. Bliley, Tom [R-VA-7], Rep. Sikorski, Gerry E. [D-MN-6], Rep. Oxley, Michael G. [R-OH-4], Rep. Luken, Thomas A. [D-OH-1], Rep. Eckert, Fred J. [R-NY-30], Rep. Bryant, John W. [D-TX-5], Rep. Whittaker, Bob [R-KS-5], Rep. Nichols, Bill [D-AL-3], Rep. DioGuardi, Joseph J. [R-NY-20], Rep. Lloyd, Marilyn [D-TN-3], Rep. Hammerschmidt, John P. [R-AR-3], Rep. Darden, George (Buddy) [D-GA-7], Rep. de la Garza, E. [D-TX-15], Rep. Schroeder, Patricia [D-CO-1], Rep. Murtha, John P. [D-PA-12], Rep. McDade, Joseph M. [R-PA-10], Rep. Barnard, Doug, Jr. [D-GA-10], Rep. Lent, Norman F. [R-NY-4], Rep. Shaw, E. Clay, Jr. [R-FL-22], Sen. Akaka, Daniel K. [D-HI], Rep. Pickle, J. J. [D-TX-10], Sen. Carper, Thomas R. [D-DE], Rep. Levin, Sander M. [D-MI-12], Rep. Hall, Ralph M. [R-TX-4], Rep. Valentine, Tim [D-NC-2], Rep. Boner, William H. [D-TN-5], Rep. Spence, Floyd [R-SC-2], Rep. Hayes, Charles A. [D-IL-1], Sen. Breaux, John B. [D-LA], Rep. Bustamante, Albert G. [D-TX-23], Rep. Kostmayer, Peter H. [D-PA-8]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Official sourceView documentsShare

Summary

Prescription Drug Marketing Act of 1986 - Amends the Federal Food, Drug, and Cosmetic Act to permit only the U.S. manufacturer of a drug to reimport such drug into the United States. Prohibits the sale of prescription drug samples. Permits the distribution of samples only to practitioners licensed to prescribe such drugs. Requires such practitioners to return a receipt for such drug samples to the manufacturers to be kept and made available to Federal and State officials. Requires drug wholesalers to provide drug purchasers with a statement identifying the manufacturer and each sale of the drug. Directs the Secretary of Health and Human Services to issue licensing standards for drug wholesalers.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 14 May 1986

    Introduced

    Referred to House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 14 May 1986

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 14 May 1986

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 22 May 1986

    Referred

    Referred to Subcommittee on Health and the Environment.

    Source: Committee

  5. 23 September 1986

    Committee

    Forwarded by Subcommittee to Full Committee (Amended).

    Source: Committee

  6. 23 September 1986

    Committee

    Subcommittee Consideration and Mark-up Session Held.

    Source: Committee

  7. 7 October 1986

    Reported

    Ordered to be Reported (Amended).

    Source: Committee

  8. 7 October 1986

    Committee

    Committee Consideration and Mark-up Session Held.

    Source: Committee

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.